• to decreased the chance of significant cardiovascular (heart and blood vessel) troubles in adults with form 2 diabetes and cardiovascular diseaseCalifornia biotech behemoth Amgen ditched ideas for an experimental weight loss pill in May but remains to be hoping to get a slice of the market with MariTide, a month to month injection that's taken